CogState

CogState Gross Profit

The Gross Profit of CogState (CGS.AX) as of Oct 17, 2026 is 32.14 M USD. In the previous year, Gross Profit was 24.30 M USD — a change of 32.24% (higher).

Gross Profit

32.14 MUSD

YoY

32.24%

Last updated:

Gross Profit of CogState is 2025 32.14 M USD. Gross Profit of CogState was 2024 24.30 M USD. It decreases by 32.24% higher compared to the previous year.

The CogState Gross Profit history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Profit
Date
Gross Profit
Jan 1, 2018
15.93 M USD
Jan 1, 2019
9.84 M USD
Jan 1, 2020
9.20 M USD
Jan 1, 2021
17.49 M USD
Jan 1, 2022
26.34 M USD
Jan 1, 2023
20.65 M USD
Jan 1, 2024
24.30 M USD
Jan 1, 2025
32.14 M USD
The CogState Gross Profit history
YEARGross ProfitYoY
32.14 MUSD+32.24%
24.30 MUSD+17.70%
20.65 MUSD-21.60%
26.34 MUSD+50.57%
17.49 MUSD+90.19%
9.20 MUSD-6.57%
9.84 MUSD-38.23%
15.93 MUSD+15.97%
13.74 MUSD+28.44%
10.70 MUSD+102.53%
5.28 MUSD+8.24%
4.88 MUSD-33.06%
7.29 MUSD-9.33%
8.04 MUSD+81.49%
4.43 MUSD-11.75%
5.02 MUSD+19.81%
4.19 MUSD+25.45%
3.34 MUSD+86.59%
1.79 MUSD+21.77%
1.47 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CogState Revenue

CogState Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
40.45 M USD
3.11 M USD
3.57 M USD
Jan 1, 2024
43.43 M USD
7.07 M USD
5.45 M USD
Jan 1, 2025
53.09 M USD
13.07 M USD
10.14 M USD
Jan 1, 2026 (e)
128.65 M USD
23.06 M USD
16.22 M USD
Jan 1, 2027 (e)
108.90 M USD
30.91 M USD
22.41 M USD
Jan 1, 2028 (e)
124.70 M USD
38.83 M USD
27.76 M USD
Jan 1, 2029 (e)
142.14 M USD
47.36 M USD
33.64 M USD
Jan 1, 2030 (e)
150.15 M USD
26.65 M USD
25.73 M USD

CogState Margins

CogState stock margins

The CogState margin analysis displays the gross margin, EBIT margin, as well as the profit margin of CogState. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for CogState.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
51.04 %
7.68 %
8.82 %
Jan 1, 2024
55.96 %
16.29 %
12.55 %
Jan 1, 2025
60.53 %
24.63 %
19.11 %
Jan 1, 2026 (e)
60.53 %
17.92 %
12.61 %
Jan 1, 2027 (e)
60.53 %
28.38 %
20.58 %
Jan 1, 2028 (e)
60.53 %
31.14 %
22.26 %
Jan 1, 2029 (e)
60.53 %
33.32 %
23.67 %
Jan 1, 2030 (e)
60.53 %
17.75 %
17.14 %

CogState Stock analysis

What does CogState do? CogState Ltd is an Australian company specializing in the development of innovative cognitive tests. The company was founded in 1999 and is based in Melbourne, Australia. It conducts computer-based cognitive tests to gather information about the cognitive functioning of patients and athletes. The CogState tests are specifically designed to measure cognitive abilities in areas such as perception, reaction time, memory, and attention. The business model of CogState is based on the development, marketing, and sale of cognitive test products. The company generates a significant portion of its revenue through licensing its tests to pharmaceutical and biotech companies that want to test their medications or therapies more effectively. CogState also has a strong presence in the sports industry, offering its tests to sports teams and individual athletes. CogState was founded in 1999 by Paul Maruff, a neuropsychologist, who was searching for better and more effective ways to conduct cognitive tests. Initially, the tests developed by CogState were exclusively for medical research, but it was quickly discovered that they could be useful in other areas as well. In 2004, Richard Kimber joined the company as CEO and Chairman, bringing his experience from the biotechnology industry. CogState offers a variety of cognitive tests for various applications, including clinical trials, sports performance analysis, and brain injury treatment. The tests are licensed by different companies and organizations that use them to test the effects of medications and therapies on cognitive functions or to assess performance and injuries in sports. One example of a CogState product is the AX Continuous Tracker Test. This test was developed for clinical use and allows for continuous and accurate measurement of cognitive functions in patients with psychiatric and neurological disorders. Another application is the SPARQ test for athletes, which allows for the measurement and improvement of athletes' cognitive abilities. In summary, CogState Ltd is a leading company in the field of cognitive tests. The company specializes in developing innovative cognitive tests for the specific requirements of pharmaceutical and biotech companies, as well as sports organizations. The tests are used worldwide by various organizations and have a significant impact on the treatment of psychiatric and neurological disorders, as well as performance and injury analysis in sports. CogState is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CogState stock

Gross Profit of CogState is 32.14 M USD in 2025.

Gross Profit of CogState changed from 24.30 M USD to 32.14 M USD, representing a 32.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Profit CogState since 2006 – with annual values, charts, and detailed analysis.

Gross Profit is the revenue remaining after deducting the cost of goods sold. It shows how efficiently a company uses its resources to produce goods or services.

Gross Profit's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Gross Profit's CogState historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — CogState

All Key Metrics — CogState